Search clinical trials for: EMN

Total 2293 results

Hospital do Servidor Publico Estadual

Unknown

The Effects of Caffeine on Vestibular Evoked Myogenic Potentials in Healthy Subjects

Healthy Subjects

Brazil
Medical University of Vienna

Completed

The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers

Healthy Human Male Subjects

Austria
Bukwang Pharmaceutical

Completed

A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects (BKP-1003-101)

Healthy

Korea, Republic of
Università degli Studi 'G. d'Annunzio' Chieti e...

Completed

Pharmacological Cognitive Enhancement (MODREST)

Fluid Inteligence | Modafinil | Healthy Young Subjects | Resting State Networks

Italy
University Hospital, Basel, Switzerland

Completed

Effects of Melatonin and Oxygen Consumption and Choroidal Blood Flow (MelO2)

Vasospastic Syndrome

Switzerland
Silbiotech

Unknown

Biomarker Breast Pap Test

Tumors
5 Santé
Institut National de la Santé Et de la Recherche Médicale, France; Centre Hospitalier...

Completed

Effects of Training in Healthy Sedentary Subjects

Sedentary Subjects

France
Purdue Pharma LP

Completed

Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods

Healthy

United States
Purdue Pharma LP

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

Healthy Volunteers

United States
Hadassah Medical Organization
Meridian Bioscience, Inc.

Unknown

¹³C-Methacetin Breath Test (MBT) Methodology Study

Cirrhosis | Healthy Subjects | Chronic Liver Disease

Israel
UCB Pharma

Completed

A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Pneumococcal Vaccine in Healthy Infants

Pneumococcal Infections | Healthy Subjects

United States
Azidus Brasil

Unknown

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.

Healthy

Brazil
Ono Pharma USA Inc

Completed

Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects

Healthy

United States
InQpharm Group

Completed

Effect of Litramine on Fat Excretion

Healthy Subjects

Germany
Gilead Sciences

Completed

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C

United States, Puerto Rico
Metabolic Technologies Inc.
Iowa State University

Completed

Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate

Healthy

United States
National Taiwan University Hospital
National Science Council, Taiwan

Completed

The Pharmacokinetic Study of Red Yeast Rice Capsule Compared to Lovastatin Tablet in Healthy Subjects

Healthy Subjects

Taiwan
Charite University, Berlin, Germany
Karl and Veronica Carstens Foundation

Completed

Homeopathic Drug Proving Trial (HAMSV)

Healthy Subjects

Germany
Eisai Co., Ltd.

Completed

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Healthy Adult

Japan
AstraZeneca

Completed

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects

Pharmacokinetics | Safety

Japan
Ruhr University of Bochum

Completed

Correlation Between 3 Phase Bone Scintigraphy and Pressure Pain Thresholds in Patients With Complex Regional Pain Syndrome (CRPS)

Healthy Subjects | Complex Regional Pain Syndrome Type I of the Upper Limb | Unilateral Limb Pain of Other Origin

Germany
Ono Pharma USA Inc

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Completed

ONO-7746 Study in Healthy Adult Subject

Healthy Adult Subjects

United States
Ono Pharma USA Inc

Completed

Single Dose Escalation Study of ONO-9054 in Healthy Volunteers

Healthy Adult Subjects

United States
Ono Pharma USA Inc

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Completed

ONO-7746 Study in Healthy Adult Subjects

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Terminated

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Healthy Adult Subjects

United Kingdom
Ono Pharma USA Inc

Completed

Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects

Healthy Adult Subjects

United States
Mannkind Corporation

Completed

A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration.

Healthy Subjects

United States
Mannkind Corporation

Completed

A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers

Diabetes Mellitus | Healthy Subjects

United Kingdom
Mannkind Corporation

Completed

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

Diabetes Mellitus | Asthma

United Kingdom
GlaxoSmithKline

Completed

Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.

Healthy Subjects | Dyslipidaemia | Dyslipidaemias

United Kingdom
AVEO Pharmaceuticals, Inc.

Completed

A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects

Food Effect of Tivozanib in Health Subjects

United States
Astellas Pharma Europe B.V.

Completed

Drug to Drug Interaction Study With Ipragliflozin and Furosemide

Healthy Subjects | Pharmacokinetics of Ipragliflozin

United Kingdom
GlaxoSmithKline

Completed

An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.

Sleep Initiation and Maintenance Disorders | Healthy Subjects

United Kingdom
Astellas Pharma Europe B.V.

Completed

Absolute Bioavailability Study With Ipragliflozin

Healthy Subjects | Bioavailability of Ipragliflozin

United Kingdom
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1 Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Tivozanib in Healthy Subjects

Healthy

United States
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy Subjects

Healthy

United States
GlaxoSmithKline

Completed

A Second Study to Determine the Effect of GSK256073A on HVTs

Healthy Subjects | Dyslipidaemias

United States
GlaxoSmithKline

Completed

Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers

Healthy Subjects | Dyslipidaemias

United States
GlaxoSmithKline

Completed

GSK372475 Bioequivalence Study

Depressive Disorder | Healthy Subjects

Canada
GlaxoSmithKline

Completed

Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males

Healthy Subjects | Depressive Disorder and Anxiety Disorders

Canada
AstraZeneca

Completed

Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

Healthy
AstraZeneca

Completed

Oral Mucosal Absorption of ICI176,334-1

Healthy
UCB Pharma

Completed

Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)

Healthy

United Kingdom
Puma Biotechnology, Inc.

Completed

Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

Healthy Subjects

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)

Healthy Subjects

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating The Tolerability Of Multiple Doses Of HKI-272

Healthy Subjects

United States
Puma Biotechnology, Inc.

Completed

Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin

Healthy

United States

3

Subscribe